Medicare Enrolled

Dr. Randall Maxey, MD PHD

Nephrology · Inglewood, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
447 N PRAIRIE AVE, Inglewood, CA 90301
3106801810
In practice since 2006 (19 years)
NPI: 1700944279 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maxey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maxey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maxey

Dr. Randall Maxey is a nephrology specialist in Inglewood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Maxey performed 2,656 Medicare services across 864 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maxey received a total of $5,244 from 20 pharmaceutical and/or device companies across 40 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maxey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 20% volume in CA $5,244 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,656
Medicare services
Top 20% in CA for nephrology
864
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~140 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Home visit, established patient, moderate complexity
A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service.
744 $97 $388
Home visit, established patient, low complexity
A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes.
513 $61 $249
Home health agency supervision, complex multidisciplinary care
Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision.
228 $89 $289
Home health plan of care re-certification
A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present.
210 $36 $127
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
172 $101 $216
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
164 $106 $214
Home visit, established patient, high complexity
A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes.
140 $129 $478
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
87 $46 $78
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
87 $42 $66
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
84 $45 $153
Remote vital sign monitoring management, each additional 20 minutes
This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period.
83 $34 $56
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
81 $140 $344
Psychological test evaluation, first hour
A healthcare professional evaluates the results of psychological testing during an initial one-hour session.
16 $77 $194
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
16 $30 $66
Home visit, new patient, high complexity
A home visit for a new patient involving high-level medical decision making, lasting at least 75 minutes.
16 $117 $505
Remote physiologic monitoring setup and education
Initial setup of remote monitoring equipment and patient education on its use.
15 $17 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,244
Total received (2018-2024)
Avg $749/year across 7 years
Top 19% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
40
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,870 (54.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,307 (24.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,068 (20.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$64
2023
$348
2022
$226
2021
$2,297
2020
$1,775
2019
$144
2018
$390

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$33
GlaxoSmithKline, LLC.
$17
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$2,850
Takeda Pharmaceuticals U.S.A., Inc.
$1,068
AstraZeneca Pharmaceuticals LP
$323
Indivior Inc.
$198
ViiV Healthcare Company
$123
GlaxoSmithKline, LLC.
$121
Gilead Sciences, Inc.
$119
Alnylam Pharmaceuticals Inc.
$105
Bayer Healthcare Pharmaceuticals Inc.
$52
LINUS HEALTH, INC.
$46
ARBOR PHARMACEUTICALS, INC.
$46
Novartis Pharmaceuticals Corporation
$35
Kyowa Kirin, Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$26
Relypsa, Inc.
$23
Horizon Therapeutics plc
$21
Novo Nordisk Inc
$17
Otsuka America Pharmaceutical, Inc.
$17
Horizon Pharma plc
$15
Alkermes, Inc.
$11
Top 3 companies account for 80.9% of all-time payments
Associated products mentioned in payments ›
APRETUDE · BREZTRI AEROSPHERE · CORE COGNITIVE EVALUATION · Descovy · ENTYVIO · Edarbi · FARXIGA · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · ONPATTRO · Ozempic · SHINGRIX · SUBLOCADE · SYMBICORT · TRELEGY ELLIPTA · Truvada · VYNDAQEL · Veltassa · Vivitrol 380 mg
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a nephrology specialist in Inglewood?
Compare nephrologists in the Inglewood area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
356
Per 100K population
3.6
County median income
$87,760
Nearest hospital
CENTINELA HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Maxey is a mixed practice specialist, with above-average Medicare volume (top 20% in CA), with speaking/promotional industry engagement in the top 19% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Maxey experienced with home visit, established patient, moderate complexity?
Based on Medicare claims data, Dr. Maxey performed 744 home visit, established patient, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maxey receive payments from pharmaceutical companies?
Yes. Dr. Maxey received a total of $5,244 from 20 companies across 40 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maxey's costs compare to other nephrologists in Inglewood?
Dr. Maxey's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maxey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →